| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
EndothelinBosentanPulmonal hypertensionIloprostSitaxsentanEpoprostenolSildenafil| 1 | 2002 | Endothelin antagonism with bosentan: current status and future perspectives. | 
| + | - | nl | Cardiovasc Drug Rev 20(1):1-18 (2002) |
| 2 | 2009 | Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient. | 
| + | - | nl | Vasc Health Risk Manag 5(-):607-19 (2009) |
| 3 | 2007 | Review of bosentan in the management of pulmonary arterial hypertension. | 
| + | - | nl | Vasc Health Risk Manag 3(6):887-900 (2007) |
| 4 | 2009 | Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation. | 
| + | - | nl | Health Technol Assess 13(49):1-320 (2009) |